Stockscreener 앱 받기
81.35
0.43%
-0.35
시간 외 거래:
81.35
전일 마감가:
$81.70
열려 있는:
$82.33
하루 거래량:
447.87K
Relative Volume:
0.80
시가총액:
$3.45B
수익:
$17.39M
순이익/손실:
$-135.89M
주가수익비율:
-17.53
EPS:
-4.64
순현금흐름:
$-123.00M
1주 성능:
-0.51%
1개월 성능:
+8.74%
6개월 성능:
+98.66%
1년 성능:
+59.26%
1일 변동 폭
$80.51
$83.33
1주일 범위
$78.10
$85.25
52주 변동 폭
$38.51
$85.25
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
명칭
Tarsus Pharmaceuticals Inc
전화
(949) 409-9820
주소
15440 LAGUNA CANYON ROAD, IRVINE
TARS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
81.35 | 3.47B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-20 | 개시 | Mizuho | Outperform |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-27 | 재개 | H.C. Wainwright | Buy |
| 2023-11-20 | 개시 | Goldman | Neutral |
| 2023-07-18 | 개시 | William Blair | Outperform |
| 2023-05-18 | 개시 | Guggenheim | Buy |
| 2022-08-01 | 개시 | Barclays | Overweight |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-23 | 개시 | Oppenheimer | Outperform |
| 2020-11-10 | 개시 | BofA Securities | Buy |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Ladenburg Thalmann | Buy |
| 2020-11-10 | 개시 | Raymond James | Strong Buy |
모두보기
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
TFG Asset Management GP Ltd Grows Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Trading the Move, Not the Narrative: (TARS) Edition - news.stocktradersdaily.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Upgraded at Barclays - MarketBeat
Tarsus Pharmaceuticals chief medical officer talks AI in eye care - Healthcare Brew
Barclays Initiates Coverage on Tarsus Pharmaceuticals (TARS) wit - GuruFocus
Jump Financial LLC Purchases 188,317 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Norges Bank Acquires Shares of 471,354 Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month HighHere's What Happened - MarketBeat
Tarsus Pharmaceuticals stock hits all-time high at 83.67 USD - Investing.com
Tarsus Pharmaceuticals Leads Six-Month Stock Performance with 85.5% Return - Markets Mojo
Quantbot Technologies LP Purchases 24,319 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Can Tarsus Pharmaceuticals Stock Still Offer Value After Its 48% 2025 Rally? - Yahoo Finance
Tarsus Pharmaceuticals (TARS): Revisiting Valuation After a Strong Multi‑Year Share Price Run - Sahm
Quadrature Capital Ltd Invests $588,000 in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
(TARS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Virtus Investment Advisers LLC Buys 3,827 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. $TARS Shares Bought by Prudential Financial Inc. - MarketBeat
Geode Capital Management LLC Raises Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Can Tarsus Pharmaceuticals Inc. stock double in next 5 years - moha.gov.vn
Why Tarsus Pharmaceuticals Inc. stock could rally in 2025Portfolio Gains Summary & Risk Adjusted Buy/Sell Alerts - moha.gov.vn
Magnetar Financial LLC Takes $596,000 Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Hits New 1-Year HighHere's What Happened - MarketBeat
Tarsus to Participate in Upcoming Investor Conference - The Manila Times
Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Profit Outlook - 富途牛牛
Tarsus Pharmaceuticals, Inc. $TARS Shares Acquired by SG Americas Securities LLC - MarketBeat
Will Tarsus Pharmaceuticals Inc. stock maintain dividend yieldMarket Trend Summary & Fast Gain Swing Alerts - newser.com
Tarsus Pharmaceuticals (TARS) Is Up 6.1% After Analyst Upgrades Highlight XDEMVY Sales Momentum - Sahm
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 (NASDAQ:TARS) - Seeking Alpha
Mizuho Initiates Coverage on Tarsus Pharmaceuticals (TARS) with Outperform Rating | TARS Stock News - GuruFocus
Mizuho initiates coverage on Tarsus Pharmaceuticals stock with Outperform rating - Investing.com Canada
Mizuho Initiates Tarsus Pharmaceuticals at Outperform With $100 Price Target - MarketScreener
Will Tarsus Pharmaceuticals Inc. stock remain a Wall Street favoriteWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Price-Driven Insight from (TARS) for Rule-Based Strategy - news.stocktradersdaily.com
Will Tarsus Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com
What catalysts could drive Tarsus Pharmaceuticals Inc. stock higherMarket Movement Recap & Daily Oversold Stock Bounce Ideas - newser.com
Is Tarsus Pharmaceuticals Inc. stock poised for growth2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
Can Tarsus Pharmaceuticals Inc. stock resist market sell offs2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 1-Year HighTime to Buy? - MarketBeat
Long term hold vs stop loss in Tarsus Pharmaceuticals Inc.Market Performance Summary & Fast Entry Momentum Alerts - newser.com
Midday Stock Roundup: Eledon Falls after Trial Report - Orange County Business Journal
Tarsus Pharmaceuticals stock hits all-time high at 76.85 USD By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals Inc (TARS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):